Cresco Labs (CRLBF) Amortizatization of Intangibles (2020 - 2026)
Cresco Labs (CRLBF) reported Amortizatization of Intangibles of $1.9 million for Q1 2026, up 5.41% on a YoY basis from $1.8 million in Q1 2025, and up 22.9% quarter-over-quarter from $1.5 million in Q4 2025.
Cresco Labs (CRLBF) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Cresco Labs has reported Amortizatization of Intangibles for 7 years, with the latest figure at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 5.41% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 5.93% YoY), and the FY2025 full-year result was $7.0 million, up 1.88% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $1.9 million, up from $1.5 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.0 million in Q1 2024, with the low at $1.1 million in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $1.7 million across 5 years, with a median of $1.7 million in 2023.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 39.51% — and 2023, when it surged 50.99%.
- Cresco Labs' Amortizatization of Intangibles stood at $1.2 million in 2022, then jumped by 41.85% to $1.7 million in 2023, then gained by 1.58% to $1.7 million in 2024, then fell by 11.26% to $1.5 million in 2025, then advanced by 22.9% to $1.9 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.9 million (Q1 2026), $1.5 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Cresco Labs | - | - | 75.45 Mn | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |